Virbac SA (VIRP.PA)
Company Info
ISIN | FR0000031577 |
---|---|
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Highlights
Market Cap | €2.91B |
---|---|
EPS (TTM) | €14.39 |
PE Ratio | 24.15 |
Total Revenue (TTM) | €636.43M |
Gross Profit (TTM) | €213.22M |
EBITDA (TTM) | €95.46M |
Year Range | €238.10 - €376.08 |
Target Price | €388.80 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in Virbac SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Virbac SA had a return of -2.97% year-to-date (YTD) and 26.38% in the last 12 months. Over the past 10 years, Virbac SA had an annualized return of 8.93%, while the S&P 500 had an annualized return of 10.95%, indicating that Virbac SA did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -2.97% | 18.42% |
1 month | -1.28% | 2.28% |
6 months | 2.90% | 9.95% |
1 year | 26.38% | 25.31% |
5 years (annualized) | 15.60% | 14.08% |
10 years (annualized) | 8.93% | 10.95% |
Monthly Returns
The table below presents the monthly returns of VIRP.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -7.09% | -0.60% | 4.22% | 0.29% | 3.17% | -8.45% | 7.81% | -2.97% | |||||
2023 | 22.15% | 1.62% | 4.59% | 4.56% | -7.92% | -4.63% | 3.51% | -1.43% | -7.25% | 5.86% | 5.72% | 25.48% | 58.43% |
2022 | -16.25% | 2.95% | -0.82% | 6.34% | -1.94% | -1.50% | -3.10% | 2.78% | -27.84% | -7.12% | -1.81% | -6.37% | -46.10% |
2021 | -9.87% | -5.59% | 8.40% | 23.01% | -1.11% | 8.53% | 17.82% | 5.14% | 3.63% | 17.92% | -5.37% | 2.54% | 78.84% |
2020 | -6.55% | -7.01% | -21.17% | 11.11% | 5.56% | 2.63% | -5.33% | 1.84% | 5.11% | 1.11% | 8.61% | 9.68% | 0.63% |
2019 | 8.08% | -6.02% | 26.47% | 8.62% | 6.17% | -0.24% | -0.24% | 0.48% | 24.56% | 4.05% | 1.37% | 6.77% | 107.82% |
2018 | 0.08% | -0.81% | -2.61% | 8.21% | -4.02% | -5.81% | 4.45% | 8.69% | 7.84% | -0.84% | -14.95% | -5.64% | -7.85% |
2017 | 2.06% | -0.79% | -13.32% | -1.50% | 1.18% | -3.93% | 7.30% | -6.83% | -11.39% | -11.17% | -1.76% | 13.72% | -26.14% |
2016 | -22.93% | -0.35% | -9.51% | 4.29% | -2.73% | 5.52% | 7.77% | 4.77% | -19.42% | -2.52% | -11.62% | 30.47% | -23.93% |
2015 | 13.14% | 21.37% | -8.04% | 5.45% | -5.49% | -11.64% | 12.50% | -5.14% | -24.60% | 17.38% | 6.09% | 14.24% | 27.30% |
2014 | 6.70% | 9.08% | -10.37% | 6.64% | -0.72% | -0.50% | -5.16% | -5.13% | 9.72% | 7.15% | 0.90% | -3.19% | 13.53% |
2013 | 10.11% | -0.06% | 8.98% | -13.75% | 7.90% | -3.77% | -5.66% | -7.60% | 8.23% | -1.23% | -2.40% | 7.40% | 4.91% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of VIRP.PA is 76, placing it in the top 24% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Virbac SA (VIRP.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Virbac SA granted a 0.38% dividend yield in the last twelve months. The annual payout for that period amounted to €1.32 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | €1.32 | €1.32 | €1.25 | €0.75 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.90 | €1.90 | €1.90 |
Dividend yield | 0.38% | 0.37% | 0.55% | 0.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.86% | 1.09% | 1.22% |
Monthly Dividends
The table displays the monthly dividend distributions for Virbac SA. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.32 | €0.00 | €0.00 | €1.32 | ||||
2023 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.32 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.32 |
2022 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.25 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.25 |
2021 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.75 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.75 |
2020 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2019 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2018 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2017 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2016 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
2015 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.90 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.90 |
2014 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.90 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.90 |
2013 | €1.90 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 | €1.90 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Virbac SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Virbac SA was 59.27%, occurring on Nov 16, 2017. Recovery took 869 trading sessions.
The current Virbac SA drawdown is 20.60%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-59.27% | Mar 17, 2015 | 687 | Nov 16, 2017 | 869 | Apr 16, 2021 | 1556 |
-59.12% | Feb 1, 1994 | 1277 | Apr 13, 1999 | 589 | Aug 7, 2001 | 1866 |
-50.27% | Dec 14, 2021 | 263 | Dec 19, 2022 | — | — | — |
-41.79% | Jul 3, 2002 | 182 | Mar 18, 2003 | 632 | Sep 1, 2005 | 814 |
-33.04% | Jan 2, 2008 | 138 | Jul 16, 2008 | 270 | Aug 6, 2009 | 408 |
Volatility
Volatility Chart
The current Virbac SA volatility is 7.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Virbac SA compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for VIRP.PA in comparison to other companies of the Drug Manufacturers - General industry. Currently, VIRP.PA has a PE value of 24.1. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for VIRP.PA in comparison to other companies of the Drug Manufacturers - General industry. Currently, VIRP.PA has a PEG value of 0.0. This PEG value is considered to be low compared to the rest of the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Virbac SA.
Loading data...
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |